Trial suggests 1,000 mg vitamin C lowers mortality by 65%
A new clinical trial suggests that taking 1,000 milligrams of vitamin C daily could be linked to a 65% lower risk of death.
Researchers from the University of Copenhagen and Van Andel Institute tracked 109 people at higher risk for leukemia, and over three years, those on vitamin C did much better than those on a placebo.
Researchers plan larger vitamin C trial
The participants had early-stage blood conditions that sometimes turn into aggressive cancers like acute myeloid leukemia.
Scientists think vitamin C helps by boosting an enzyme called TET2, which keeps certain cancer genes in check.
Fewer people in the vitamin C group developed serious blood cancers.
Since current options for these patients are pretty limited, researchers are now planning a larger trial to see if vitamin C could become a simple way to help prevent leukemia down the line.